Josh Miller Email

Chief Accounting Officer . Exicure

Current Roles

Employees:
7
Revenue:
$11M
About
Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets. Our 3-dimensional, spherical nucleic acid (SNAâ„¢) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. Our lead programs address diseases from inflammatory disorders to oncology. SNA constructs overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues. SNA constructs exhibit unparalleled transfection efficiency into numerous cell and tissue types including the skin without carriers or transfection agents. Moreover, SNAs can be used as potent immunotherapeutic agents for the treatment of cancer or infectious disease.
Exicure Address
2430 N. Halsted Street
Skokie, IL
United States
Exicure Email

Past Companies

ExicureChief Accounting Officer
ExicureCorporate Controller
ENGIE North America Inc.Director of Accounting of SoCore Energy

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.